Last Thursday, the European Court of Justice rendered a decision in International Stem Cell Corporation v. Comptroller General of Patents, Designs and Trademarks that significantly modified the landscape for human embryonic stem cell patenting, by holding that prohibitions against patents on hESCs only apply to such cells derived from embryos that had the potential to develop into a human being.
http://ift.tt/1xNoKP9
http://ift.tt/1xNoKP9
No comments:
Post a Comment